Myelodysplastic Syndrome: Drug Therapy
Therapeutic targets Symptom relief Preservation and improvement of the quality of life Prolongation of survival time Therapy recommendations Therapy of low-risk myelodysplastic syndrome. In the presence of low-grade cytopenia (decrease in cell count) and depending on age and comorbidities (concomitant diseases), it is sufficient to initially observe or wait (“watch and wait”) in these patients. … Myelodysplastic Syndrome: Drug Therapy